Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00142740 · ClinicalTrials.gov registry record

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

A clinical trial of HIV Infection and Hepatitis B, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
337
Enrollment target
4
Study locations

NCT00142740 is a study of HIV Infection and Hepatitis B that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 337 participants, above the 238-participant average among 73 other HIV Infection trials with a reported enrollment target (42% higher). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00142740, a study of HIV Infection and Hepatitis B, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
337 participants
Enrollment target
4
Study locations

Study Summary

This laboratory-based substudy of an effectiveness trial of two Hepatitis B vaccines in HIV-negative youths is being done to evaluate the genetic contribution to the individualized immune response.

Conditions Studied

HIV Infection Hepatitis B

Study Locations (4)

California

  • Children's Hospital of Los Angeles - Los Angeles
  • University of California at San Francisco - San Franciso

District of Columbia

  • Children's Hospital National Medical Center - Washington D.C.

Florida

  • University of Southern Florida College of Medicine - Tampa

Trial Details

FieldValue
Enrollment Target 337 participants
Start Date 2005-10
Est. Completion 2008-06

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00142740

The ClinicalTrials.gov registry entry for NCT00142740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 337 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 238-participant average among 73 other HIV Infection trials with a reported enrollment target (42% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infection appearing as the primary indexed condition, and to 0 interventions.

NCT00142740 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT00142740 about?

NCT00142740 is a clinical study titled "Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025". This laboratory-based substudy of an effectiveness trial of two Hepatitis B vaccines in HIV-negative youths is being done to evaluate the genetic contribution to the individualized immune response.

What is the current status of trial NCT00142740?

This trial is currently completed. The enrollment target is 337 participants. The study started on 2005-10. Estimated completion is 2008-06.

What conditions does trial NCT00142740 study?

This clinical trial studies the following conditions: HIV Infection, Hepatitis B.

Who is sponsoring clinical trial NCT00142740?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00142740 being conducted?

This trial has 4 study locations across California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infection

All registered trials for this condition

Hepatitis B

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.